Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH)

ConclusionsMirabegron and solifenacin were commonly prescribed as first-line OAB medications. There was no treatment switch, change, or discontinuation in more than 60% of the mirabegron initiator and antimuscarinics initiator groups. Mean initial treatment duration was 130.8  days and 122.2 days for mirabegron and antimuscarinics, respectively. Graphical Abstract available for this article.Trial RegistrationClinicalTrials.gov NCT03572231.Graphical Abstract
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research